The Tyrosine Phosphatase SHP2: A New Target for Insulin Resistance? - Université Toulouse III - Paul Sabatier - Toulouse INP Accéder directement au contenu
Article Dans Une Revue Biomedicines Année : 2022

The Tyrosine Phosphatase SHP2: A New Target for Insulin Resistance?

Résumé

The SH2 containing protein tyrosine phosphatase 2(SHP2) plays essential roles in fundamental signaling pathways, conferring on it versatile physiological functions during development and in homeostasis maintenance, and leading to major pathological outcomes when dysregulated. Many studies have documented that SHP2 modulation disrupted glucose homeostasis, pointing out a relationship between its dysfunction and insulin resistance, and the therapeutic potential of its targeting. While studies from cellular or tissue-specific models concluded on both pros-and-cons effects of SHP2 on insulin resistance, recent data from integrated systems argued for an insulin resistance promoting role for SHP2, and therefore a therapeutic benefit of its inhibition. In this review, we will summarize the general knowledge of SHP2’s molecular, cellular, and physiological functions, explaining the pathophysiological impact of its dysfunctions, then discuss its protective or promoting roles in insulin resistance as well as the potency and limitations of its pharmacological modulation.
Fichier principal
Vignette du fichier
SAINT-LAURENT_2022.pdf (875.95 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
Licence

Dates et versions

hal-04577773 , version 1 (16-05-2024)

Licence

Identifiants

Citer

Céline Saint-Laurent, Laurène Mazeyrie, Mylène Tajan, Romain Paccoud, Isabelle Castan-Laurell, et al.. The Tyrosine Phosphatase SHP2: A New Target for Insulin Resistance?. Biomedicines, 2022, 10 (9), pp.2139. ⟨10.3390/biomedicines10092139⟩. ⟨hal-04577773⟩
2 Consultations
4 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More